F18.95
Inhalant use, unspecified with inhalant-induced psychotic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant use involves inhaling volatile substances to achieve psychoactive effects. When this behavior leads to mental health disturbances, such as psychotic symptoms, it is classified as an inhalant-induced psychotic disorder. This condition is characterized by hallucinations, delusions, or other psychotic features triggered specifically by inhalant abuse. The International Classification of Diseases, Tenth Revision (ICD-10) assigns code F18.95 to these cases, highlighting the importance of recognizing and addressing inhalant-related mental health issues.
Causes & Symptoms
Clinical Causes: Repeated inhalation of volatile solvents, aerosols, or gases found in household and industrial products Prolonged or frequent use of inhalants leading to toxicity in the brain Use of inhalants as a form of substance abuse to experience a quick 'high' Underlying mental health conditions or social factors that increase susceptibility to substance use Accessibility and low cost of certain inhalant products that are easily obtainable, especially among adolescents
Key Symptoms: Hallucinations, such as seeing or hearing things that are not present Paranoia or delusional thinking Disorganized thoughts or speech Aggressive behavior or agitation Confusion or disorientation Mood swings or emotional instability Physical symptoms like dizziness, nausea, or muscle weakness during or after inhalant use
Diagnostic & Treatment
Diagnosis Path: Diagnosis of inhalant-induced psychotic disorder involves a comprehensive evaluation by a healthcare professional, including a detailed mental health history and substance use assessment. Clinicians look for evidence of psychotic symptoms that coincide with recent inhalant use and rule out other underlying causes. Laboratory tests or toxicology screenings may assist in confirming recent inhalant exposure. The diagnosis specifically cites inhalant use as the trigger for the psychotic symptoms, aligning with the ICD-10 coding criteria.
Treatment Protocols: Treatment strategies focus on addressing both the substance abuse and the psychotic symptoms. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is F18.95 a billable ICD-10 code?
Yes, F18.95 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.95?
Clinical documentation must specify the nature of Inhalant use, unspecified with inhalant-induced psychotic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference